๐Ÿ”Ž Trials Near Me

Home โ€บ Bleeding

Bleeding clinical trials recruiting in the U.S.

42 studies for Bleeding are recruiting participants at sites across the United States.

Bleeding is the loss of blood, inside or outside the body. A hemorrhage is severe bleeding. Learn about the causes of bleeding and how to treat it.

Cities with the most studies

By state

Recently updated studies

A Phase 3 Evaluation of Sutacimig in Glanzmann Thrombasthenia

RecruitingPhase 3
Ages 12 to 70 ยท All sexes ยท Updated Nov 13, 2026 ยท NCT07935356

Pre-emptive RTO for An Early Detected Gastric Varices in CT/MR Angiogram Trial

Recruiting
Ages 18 and older ยท All sexes ยท Updated Nov 12, 2026 ยท NCT07168395

Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Nov 5, 2026 ยท NCT07175428

REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis

RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Nov 5, 2026 ยท NCT07410117

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Nov 5, 2026 ยท NCT07626411

SWITCH: Apixaban vs Vitamin K in HM3

RecruitingPhase 3
Ages 18 to 80 ยท All sexes ยท Updated Nov 4, 2026 ยท NCT07471139

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Nov 4, 2026 ยท NCT06722235

CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial

RecruitingPhase 2
Ages 18 to 90 ยท All sexes ยท Updated Oct 30, 2026 ยท NCT05958342

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Oct 30, 2026 ยท NCT06948318

Delivering tAN to Reduce HMB: The LUNA Study

Recruiting
Ages 14 to 45 ยท Women ยท Updated Oct 20, 2026 ยท NCT07326722

A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B

RecruitingPhase 3
Ages 1 to 17 ยท Men ยท Updated Oct 14, 2026 ยท NCT05611801

Onyxโ„ข Liquid Embolic IDE Clinical Study

Recruiting
Ages 22 and older ยท All sexes ยท Updated Oct 13, 2026 ยท NCT06742801

Transcutaneous Auricular Vagus Enhanced Recovery in the NeuroICU

Recruiting
Ages 18 and older ยท All sexes ยท Updated Oct 7, 2026 ยท NCT07219108

Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

RecruitingPhase 3
Ages 18 and older ยท Men ยท Updated Oct 7, 2026 ยท NCT05568719

Impact of IV Iron on Bleeding Symptoms in Iron Deficient Patients With Inherited Bleeding Disorders

RecruitingObservational study
Ages 15 and older ยท All sexes ยท Updated Oct 6, 2026 ยท NCT07083583

Comparing the Safety and Efficacy of Apixaban and Rivaroxaban

RecruitingPhase 4
Ages 22 and older ยท All sexes ยท Updated Sep 23, 2026 ยท NCT06953726

Oil Pulling Reduction

Recruiting
Ages 18 to 70 ยท All sexes ยท Updated Aug 24, 2026 ยท NCT07706647

Oxytocin Pharmacokinetics and Pharmacodynamics

RecruitingPhase 2
Ages 18 to 50 ยท Women ยท Updated Aug 21, 2026 ยท NCT05488457

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

RecruitingObservational studyHealthy volunteers welcome
Ages 0 to 20 ยท All sexes ยท Updated Aug 21, 2026 ยท NCT04278404

Lidocaine Infusion Treatment for Subarachnoid Hemorrhage Headaches

RecruitingObservational study
Ages 18 and older ยท All sexes ยท Updated Jul 10, 2026 ยท NCT06582810

Auricular VNS Following Intracerebral Hemorrhage

Recruiting
Ages 18 and older ยท All sexes ยท Updated Jul 6, 2026 ยท NCT06799390

Improving Outcomes for Patients With Life-Threatening Neurologic Illness

RecruitingObservational study
Ages 18 and older ยท All sexes ยท Updated Jul 2, 2026 ยท NCT04189471

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Jun 26, 2026 ยท NCT04045665

Outcomes and Quality of Life Following Rectal Artery Embolization for Bleeding Internal Hemorrhoids

RecruitingObservational study
Ages 18 to 90 ยท All sexes ยท Updated Jun 17, 2026 ยท NCT06106269

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.